Nicholas Piramal is one of the largest pharmaceutical companies in India that has successfully positioned itself as a custom manufacturer for global companies.
NPIL has business expertise in the areas of bulk drug manufacture for domestic and export markets, speciality labs and chemicals and formulation development. Formulations constitute more than 65 per cent of gross sales.
The company's sales grew at a CAGR of 21.5 per cent between 1999 and 2005 to reach a level of US$ 317 million.
Click here to Download File (Size: 516.58 KB )